462 related articles for article (PubMed ID: 25995071)
1. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
[TBL] [Abstract][Full Text] [Related]
2. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a claims-based prediction model for COPD severity.
Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
[TBL] [Abstract][Full Text] [Related]
4. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
Montes de Oca M; López Varela MV; Laucho-Contreras ME; Casas A; Schiavi E; Rey A; Silva A;
Arch Bronconeumol; 2017 Mar; 53(3):98-106. PubMed ID: 27956034
[TBL] [Abstract][Full Text] [Related]
5. The distribution of COPD in UK general practice using the new GOLD classification.
Haughney J; Gruffydd-Jones K; Roberts J; Lee AJ; Hardwell A; McGarvey L
Eur Respir J; 2014 Apr; 43(4):993-1002. PubMed ID: 24176990
[TBL] [Abstract][Full Text] [Related]
6. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
[TBL] [Abstract][Full Text] [Related]
7. Multicomponent indices to predict survival in COPD: the COCOMICS study.
Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de Torres JP; Martínez-Camblor P; Miravitlles M; Celli BR; Soriano JB
Eur Respir J; 2013 Aug; 42(2):323-32. PubMed ID: 23222874
[TBL] [Abstract][Full Text] [Related]
8. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
9. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
[TBL] [Abstract][Full Text] [Related]
10. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.
Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P
Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268
[TBL] [Abstract][Full Text] [Related]
12. Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.
Tejero E; Prats E; Casitas R; Galera R; Pardo P; Gavilán A; Martínez-Cerón E; Cubillos-Zapata C; Del Peso L; García-Río F
Am J Respir Crit Care Med; 2017 Aug; 196(3):298-305. PubMed ID: 28306326
[TBL] [Abstract][Full Text] [Related]
13. Resting heart rate is a predictor of mortality in COPD.
Jensen MT; Marott JL; Lange P; Vestbo J; Schnohr P; Nielsen OW; Jensen JS; Jensen GB
Eur Respir J; 2013 Aug; 42(2):341-9. PubMed ID: 23143550
[TBL] [Abstract][Full Text] [Related]
14. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
[TBL] [Abstract][Full Text] [Related]
15. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.
Marçôa R; Rodrigues DM; Dias M; Ladeira I; Vaz AP; Lima R; Guimarães M
COPD; 2018 Feb; 15(1):21-26. PubMed ID: 29161163
[TBL] [Abstract][Full Text] [Related]
16. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
[TBL] [Abstract][Full Text] [Related]
18. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Hsu CH; Hsiue TR
J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
[TBL] [Abstract][Full Text] [Related]
19. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data.
García Castillo E; Alonso Pérez T; Ancochea J; Pastor Sanz MT; Almagro P; Martínez-Camblor P; Miravitlles M; Rodríguez-Carballeira M; Navarro A; Lamprecht B; Ramírez-García Luna AS; Kaiser B; Alfageme I; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Celli BR; Marín JM; Ter Riet G; Sobradillo P; Lange P; Garcia-Aymerich J; Anto JM; Turner AM; Han MK; Langhammer A; Vikjord SAA; Sternberg A; Leivseth L; Bakke P; Johannessen A; Oga T; Cosío BG; Echazarreta A; Roche N; Burgel PR; Sin DD; Puhan MA; López-Campos JL; Carrasco L; Soriano JB
ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263033
[TBL] [Abstract][Full Text] [Related]
20. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
